nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—GABRR3—retina—malignant glioma	0.0126	0.0286	CbGeAlD
Flurazepam—GABRQ—telencephalon—malignant glioma	0.0116	0.0263	CbGeAlD
Flurazepam—GABRR2—retina—malignant glioma	0.0109	0.0248	CbGeAlD
Flurazepam—GABRR1—retina—malignant glioma	0.0105	0.0239	CbGeAlD
Flurazepam—GABRA6—brainstem—malignant glioma	0.00906	0.0206	CbGeAlD
Flurazepam—Lucanthone—TOP2A—malignant glioma	0.00843	0.256	CrCbGaD
Flurazepam—GABRD—telencephalon—malignant glioma	0.0084	0.0191	CbGeAlD
Flurazepam—GABRG1—telencephalon—malignant glioma	0.00809	0.0184	CbGeAlD
Flurazepam—GABRA6—telencephalon—malignant glioma	0.00804	0.0183	CbGeAlD
Flurazepam—GABRB1—telencephalon—malignant glioma	0.00784	0.0178	CbGeAlD
Flurazepam—GABRA5—telencephalon—malignant glioma	0.0078	0.0177	CbGeAlD
Flurazepam—GABRA4—telencephalon—malignant glioma	0.00708	0.0161	CbGeAlD
Flurazepam—GABRB2—brainstem—malignant glioma	0.00667	0.0151	CbGeAlD
Flurazepam—Thinking abnormal—Carmustine—malignant glioma	0.00662	0.0402	CcSEcCtD
Flurazepam—GABRD—medulla oblongata—malignant glioma	0.0066	0.015	CbGeAlD
Flurazepam—GABRQ—central nervous system—malignant glioma	0.00659	0.015	CbGeAlD
Flurazepam—GABRG1—medulla oblongata—malignant glioma	0.00636	0.0144	CbGeAlD
Flurazepam—Gait disturbance—Carmustine—malignant glioma	0.00621	0.0377	CcSEcCtD
Flurazepam—GABRB1—medulla oblongata—malignant glioma	0.00616	0.014	CbGeAlD
Flurazepam—GABRA2—brainstem—malignant glioma	0.0061	0.0138	CbGeAlD
Flurazepam—GABRD—midbrain—malignant glioma	0.00604	0.0137	CbGeAlD
Flurazepam—Gait disturbance—Temozolomide—malignant glioma	0.006	0.0365	CcSEcCtD
Flurazepam—GABRB2—telencephalon—malignant glioma	0.00592	0.0134	CbGeAlD
Flurazepam—GABRG2—telencephalon—malignant glioma	0.00592	0.0134	CbGeAlD
Flurazepam—GABRA1—brainstem—malignant glioma	0.00589	0.0134	CbGeAlD
Flurazepam—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00586	0.0356	CcSEcCtD
Flurazepam—GABRG1—midbrain—malignant glioma	0.00581	0.0132	CbGeAlD
Flurazepam—GABRG3—central nervous system—malignant glioma	0.00577	0.0131	CbGeAlD
Flurazepam—GABRG1—spinal cord—malignant glioma	0.00567	0.0129	CbGeAlD
Flurazepam—GABRB1—midbrain—malignant glioma	0.00563	0.0128	CbGeAlD
Flurazepam—GABRR2—cerebellum—malignant glioma	0.00558	0.0127	CbGeAlD
Flurazepam—Coma—Carmustine—malignant glioma	0.00554	0.0336	CcSEcCtD
Flurazepam—GABRR1—central nervous system—malignant glioma	0.0055	0.0125	CbGeAlD
Flurazepam—GABRB1—spinal cord—malignant glioma	0.0055	0.0125	CbGeAlD
Flurazepam—GABRA2—telencephalon—malignant glioma	0.00541	0.0123	CbGeAlD
Flurazepam—Mental disability—Carmustine—malignant glioma	0.00526	0.0319	CcSEcCtD
Flurazepam—GABRQ—brain—malignant glioma	0.00523	0.0119	CbGeAlD
Flurazepam—GABRA1—telencephalon—malignant glioma	0.00523	0.0119	CbGeAlD
Flurazepam—Mental disability—Temozolomide—malignant glioma	0.00508	0.0309	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00489	0.0297	CcSEcCtD
Flurazepam—GABRD—central nervous system—malignant glioma	0.00478	0.0108	CbGeAlD
Flurazepam—GABRD—cerebellum—malignant glioma	0.00467	0.0106	CbGeAlD
Flurazepam—GABRB2—medulla oblongata—malignant glioma	0.00465	0.0106	CbGeAlD
Flurazepam—GABRG2—medulla oblongata—malignant glioma	0.00465	0.0106	CbGeAlD
Flurazepam—GABRG1—central nervous system—malignant glioma	0.0046	0.0104	CbGeAlD
Flurazepam—GABRG3—brain—malignant glioma	0.00458	0.0104	CbGeAlD
Flurazepam—GABRA6—central nervous system—malignant glioma	0.00457	0.0104	CbGeAlD
Flurazepam—GABRB3—telencephalon—malignant glioma	0.00455	0.0103	CbGeAlD
Flurazepam—GABRG1—cerebellum—malignant glioma	0.00449	0.0102	CbGeAlD
Flurazepam—GABRA6—cerebellum—malignant glioma	0.00447	0.0101	CbGeAlD
Flurazepam—GABRB1—central nervous system—malignant glioma	0.00446	0.0101	CbGeAlD
Flurazepam—GABRA5—central nervous system—malignant glioma	0.00444	0.0101	CbGeAlD
Flurazepam—GABRR1—brain—malignant glioma	0.00436	0.00991	CbGeAlD
Flurazepam—GABRB1—cerebellum—malignant glioma	0.00436	0.00989	CbGeAlD
Flurazepam—GABRB2—midbrain—malignant glioma	0.00425	0.00965	CbGeAlD
Flurazepam—GABRG2—midbrain—malignant glioma	0.00425	0.00965	CbGeAlD
Flurazepam—GABRB2—spinal cord—malignant glioma	0.00415	0.00942	CbGeAlD
Flurazepam—GABRG2—spinal cord—malignant glioma	0.00415	0.00942	CbGeAlD
Flurazepam—Ataxia—Carmustine—malignant glioma	0.00414	0.0251	CcSEcCtD
Flurazepam—GABRA3—central nervous system—malignant glioma	0.00413	0.00937	CbGeAlD
Flurazepam—GABRA1—medulla oblongata—malignant glioma	0.00411	0.00933	CbGeAlD
Flurazepam—GABRA4—central nervous system—malignant glioma	0.00402	0.00913	CbGeAlD
Flurazepam—Ataxia—Temozolomide—malignant glioma	0.004	0.0243	CcSEcCtD
Flurazepam—GABRA4—cerebellum—malignant glioma	0.00393	0.00893	CbGeAlD
Flurazepam—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00383	0.0233	CcSEcCtD
Flurazepam—GABRD—brain—malignant glioma	0.00379	0.00861	CbGeAlD
Flurazepam—GABRA1—midbrain—malignant glioma	0.00375	0.00852	CbGeAlD
Flurazepam—GABRA1—spinal cord—malignant glioma	0.00366	0.00832	CbGeAlD
Flurazepam—GABRG1—brain—malignant glioma	0.00365	0.00829	CbGeAlD
Flurazepam—GABRA6—brain—malignant glioma	0.00363	0.00824	CbGeAlD
Flurazepam—GABRB3—medulla oblongata—malignant glioma	0.00357	0.00811	CbGeAlD
Flurazepam—GABRB1—brain—malignant glioma	0.00354	0.00804	CbGeAlD
Flurazepam—GABRA5—brain—malignant glioma	0.00352	0.00799	CbGeAlD
Flurazepam—CYP2A6—cerebellum—malignant glioma	0.0034	0.00772	CbGeAlD
Flurazepam—ABCB1—blood vessel—malignant glioma	0.0034	0.00771	CbGeAlD
Flurazepam—GABRB2—central nervous system—malignant glioma	0.00337	0.00764	CbGeAlD
Flurazepam—GABRG2—central nervous system—malignant glioma	0.00337	0.00764	CbGeAlD
Flurazepam—GABRB2—cerebellum—malignant glioma	0.00329	0.00747	CbGeAlD
Flurazepam—GABRG2—cerebellum—malignant glioma	0.00329	0.00747	CbGeAlD
Flurazepam—GABRA3—brain—malignant glioma	0.00328	0.00744	CbGeAlD
Flurazepam—GABRB3—midbrain—malignant glioma	0.00327	0.00741	CbGeAlD
Flurazepam—Chloroquine—TNF—malignant glioma	0.00325	0.0988	CrCbGaD
Flurazepam—GABRA4—brain—malignant glioma	0.00319	0.00725	CbGeAlD
Flurazepam—GABRB3—spinal cord—malignant glioma	0.00319	0.00723	CbGeAlD
Flurazepam—GABRA2—central nervous system—malignant glioma	0.00308	0.00698	CbGeAlD
Flurazepam—GABRE—central nervous system—malignant glioma	0.00305	0.00692	CbGeAlD
Flurazepam—Hallucination—Carmustine—malignant glioma	0.00303	0.0184	CcSEcCtD
Flurazepam—GABRA2—cerebellum—malignant glioma	0.00301	0.00682	CbGeAlD
Flurazepam—GABRA1—central nervous system—malignant glioma	0.00297	0.00675	CbGeAlD
Flurazepam—Clotiazepam—CYP2C18—malignant glioma	0.00295	0.0896	CrCbGaD
Flurazepam—Hallucination—Temozolomide—malignant glioma	0.00293	0.0178	CcSEcCtD
Flurazepam—GABRA1—cerebellum—malignant glioma	0.0029	0.00659	CbGeAlD
Flurazepam—CYP2E1—telencephalon—malignant glioma	0.00289	0.00657	CbGeAlD
Flurazepam—Flushing—Carmustine—malignant glioma	0.00282	0.0172	CcSEcCtD
Flurazepam—Clobazam—CYP2C18—malignant glioma	0.00279	0.0846	CrCbGaD
Flurazepam—CYP2A6—brain—malignant glioma	0.00276	0.00627	CbGeAlD
Flurazepam—Flushing—Temozolomide—malignant glioma	0.00273	0.0166	CcSEcCtD
Flurazepam—GABRB2—brain—malignant glioma	0.00267	0.00607	CbGeAlD
Flurazepam—GABRG2—brain—malignant glioma	0.00267	0.00607	CbGeAlD
Flurazepam—GABRB3—central nervous system—malignant glioma	0.00258	0.00587	CbGeAlD
Flurazepam—GABRB3—cerebellum—malignant glioma	0.00253	0.00573	CbGeAlD
Flurazepam—Dysgeusia—Temozolomide—malignant glioma	0.00251	0.0152	CcSEcCtD
Flurazepam—Vision blurred—Carmustine—malignant glioma	0.0025	0.0152	CcSEcCtD
Flurazepam—GABRA2—brain—malignant glioma	0.00244	0.00554	CbGeAlD
Flurazepam—Agitation—Carmustine—malignant glioma	0.00243	0.0148	CcSEcCtD
Flurazepam—GABRE—brain—malignant glioma	0.00242	0.0055	CbGeAlD
Flurazepam—Vision blurred—Temozolomide—malignant glioma	0.00241	0.0147	CcSEcCtD
Flurazepam—Leukopenia—Carmustine—malignant glioma	0.00237	0.0144	CcSEcCtD
Flurazepam—GABRA1—brain—malignant glioma	0.00236	0.00536	CbGeAlD
Flurazepam—Agitation—Temozolomide—malignant glioma	0.00235	0.0143	CcSEcCtD
Flurazepam—Leukopenia—Temozolomide—malignant glioma	0.00229	0.0139	CcSEcCtD
Flurazepam—CYP2E1—medulla oblongata—malignant glioma	0.00227	0.00516	CbGeAlD
Flurazepam—Palpitations—Temozolomide—malignant glioma	0.00226	0.0137	CcSEcCtD
Flurazepam—Chest pain—Carmustine—malignant glioma	0.00226	0.0137	CcSEcCtD
Flurazepam—Anxiety—Carmustine—malignant glioma	0.00225	0.0137	CcSEcCtD
Flurazepam—Clotiazepam—CYP2B6—malignant glioma	0.00219	0.0665	CrCbGaD
Flurazepam—Confusional state—Carmustine—malignant glioma	0.00218	0.0132	CcSEcCtD
Flurazepam—Arthralgia—Temozolomide—malignant glioma	0.00218	0.0132	CcSEcCtD
Flurazepam—Anxiety—Temozolomide—malignant glioma	0.00217	0.0132	CcSEcCtD
Flurazepam—Dry mouth—Temozolomide—malignant glioma	0.00213	0.0129	CcSEcCtD
Flurazepam—Confusional state—Temozolomide—malignant glioma	0.00211	0.0128	CcSEcCtD
Flurazepam—Anaphylactic shock—Temozolomide—malignant glioma	0.00209	0.0127	CcSEcCtD
Flurazepam—Clobazam—CYP2B6—malignant glioma	0.00207	0.0628	CrCbGaD
Flurazepam—Anorexia—Carmustine—malignant glioma	0.00206	0.0125	CcSEcCtD
Flurazepam—GABRB3—brain—malignant glioma	0.00205	0.00466	CbGeAlD
Flurazepam—CYP2E1—spinal cord—malignant glioma	0.00203	0.0046	CbGeAlD
Flurazepam—ABCB1—embryo—malignant glioma	0.00203	0.0046	CbGeAlD
Flurazepam—Hypotension—Carmustine—malignant glioma	0.00202	0.0123	CcSEcCtD
Flurazepam—Hyperhidrosis—Temozolomide—malignant glioma	0.00202	0.0123	CcSEcCtD
Flurazepam—Anorexia—Temozolomide—malignant glioma	0.00199	0.0121	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00197	0.012	CcSEcCtD
Flurazepam—Clomipramine—GSTP1—malignant glioma	0.00194	0.0591	CrCbGaD
Flurazepam—Dyspnoea—Carmustine—malignant glioma	0.00193	0.0117	CcSEcCtD
Flurazepam—Somnolence—Carmustine—malignant glioma	0.00192	0.0117	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0019	0.0116	CcSEcCtD
Flurazepam—Flunitrazepam—CYP2B6—malignant glioma	0.00189	0.0575	CrCbGaD
Flurazepam—Decreased appetite—Carmustine—malignant glioma	0.00188	0.0114	CcSEcCtD
Flurazepam—Dyspnoea—Temozolomide—malignant glioma	0.00186	0.0113	CcSEcCtD
Flurazepam—Somnolence—Temozolomide—malignant glioma	0.00186	0.0113	CcSEcCtD
Flurazepam—Constipation—Carmustine—malignant glioma	0.00185	0.0112	CcSEcCtD
Flurazepam—Dyspepsia—Temozolomide—malignant glioma	0.00184	0.0112	CcSEcCtD
Flurazepam—Decreased appetite—Temozolomide—malignant glioma	0.00182	0.011	CcSEcCtD
Flurazepam—ABCB1—retina—malignant glioma	0.00179	0.00407	CbGeAlD
Flurazepam—Constipation—Temozolomide—malignant glioma	0.00179	0.0109	CcSEcCtD
Flurazepam—Feeling abnormal—Carmustine—malignant glioma	0.00178	0.0108	CcSEcCtD
Flurazepam—Gastrointestinal pain—Carmustine—malignant glioma	0.00177	0.0107	CcSEcCtD
Flurazepam—Feeling abnormal—Temozolomide—malignant glioma	0.00172	0.0105	CcSEcCtD
Flurazepam—Gastrointestinal pain—Temozolomide—malignant glioma	0.00171	0.0104	CcSEcCtD
Flurazepam—ABCB1—telencephalon—malignant glioma	0.00165	0.00374	CbGeAlD
Flurazepam—CYP2E1—central nervous system—malignant glioma	0.00164	0.00373	CbGeAlD
Flurazepam—Diazepam—CYP2C18—malignant glioma	0.00163	0.0494	CrCbGaD
Flurazepam—CYP2E1—cerebellum—malignant glioma	0.00161	0.00365	CbGeAlD
Flurazepam—Asthenia—Carmustine—malignant glioma	0.00155	0.00942	CcSEcCtD
Flurazepam—Asthenia—Temozolomide—malignant glioma	0.0015	0.00911	CcSEcCtD
Flurazepam—Diarrhoea—Carmustine—malignant glioma	0.00148	0.00899	CcSEcCtD
Flurazepam—Pruritus—Temozolomide—malignant glioma	0.00148	0.00898	CcSEcCtD
Flurazepam—Temazepam—CYP2B6—malignant glioma	0.00145	0.0441	CrCbGaD
Flurazepam—Dizziness—Carmustine—malignant glioma	0.00143	0.00869	CcSEcCtD
Flurazepam—Diarrhoea—Temozolomide—malignant glioma	0.00143	0.00868	CcSEcCtD
Flurazepam—Midazolam—CYP2B6—malignant glioma	0.00141	0.0428	CrCbGaD
Flurazepam—Dizziness—Temozolomide—malignant glioma	0.00138	0.00839	CcSEcCtD
Flurazepam—Vomiting—Carmustine—malignant glioma	0.00137	0.00835	CcSEcCtD
Flurazepam—Rash—Carmustine—malignant glioma	0.00136	0.00828	CcSEcCtD
Flurazepam—Dermatitis—Carmustine—malignant glioma	0.00136	0.00827	CcSEcCtD
Flurazepam—Headache—Carmustine—malignant glioma	0.00135	0.00823	CcSEcCtD
Flurazepam—Vomiting—Temozolomide—malignant glioma	0.00133	0.00807	CcSEcCtD
Flurazepam—CYP3A4—central nervous system—malignant glioma	0.00132	0.003	CbGeAlD
Flurazepam—Rash—Temozolomide—malignant glioma	0.00132	0.008	CcSEcCtD
Flurazepam—Dermatitis—Temozolomide—malignant glioma	0.00132	0.008	CcSEcCtD
Flurazepam—Headache—Temozolomide—malignant glioma	0.00131	0.00795	CcSEcCtD
Flurazepam—CYP2E1—brain—malignant glioma	0.00131	0.00296	CbGeAlD
Flurazepam—ABCB1—medulla oblongata—malignant glioma	0.00129	0.00294	CbGeAlD
Flurazepam—Nausea—Carmustine—malignant glioma	0.00128	0.0078	CcSEcCtD
Flurazepam—Nausea—Temozolomide—malignant glioma	0.00124	0.00754	CcSEcCtD
Flurazepam—Diazepam—CYP2B6—malignant glioma	0.00121	0.0367	CrCbGaD
Flurazepam—ABCB1—midbrain—malignant glioma	0.00118	0.00269	CbGeAlD
Flurazepam—ABCB1—spinal cord—malignant glioma	0.00115	0.00262	CbGeAlD
Flurazepam—ABCB1—central nervous system—malignant glioma	0.000937	0.00213	CbGeAlD
Flurazepam—ABCB1—cerebellum—malignant glioma	0.000915	0.00208	CbGeAlD
Flurazepam—Chlorpromazine—BCHE—malignant glioma	0.000915	0.0278	CrCbGaD
Flurazepam—Diazepam—PTGS1—malignant glioma	0.000794	0.0241	CrCbGaD
Flurazepam—ABCB1—brain—malignant glioma	0.000744	0.00169	CbGeAlD
Flurazepam—GABRA2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000225	0.00062	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000224	0.000619	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000223	0.000616	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000222	0.000614	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000222	0.000614	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.00022	0.000607	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—BRAF—malignant glioma	0.00022	0.000607	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000219	0.000606	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000219	0.000606	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000219	0.000605	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—STAT3—malignant glioma	0.000219	0.000605	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—MDM2—malignant glioma	0.000219	0.000604	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000218	0.000603	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—RAF1—malignant glioma	0.000218	0.000602	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000218	0.000602	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—MDM2—malignant glioma	0.000215	0.000595	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—COX8A—malignant glioma	0.000215	0.000594	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—RAF1—malignant glioma	0.000215	0.000593	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000214	0.000592	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—BRAF—malignant glioma	0.000214	0.00059	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000213	0.000589	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000211	0.000584	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000211	0.000582	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.00021	0.000581	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.00021	0.00058	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—BRAF—malignant glioma	0.00021	0.000579	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000209	0.000578	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000208	0.000574	CbGpPWpGaD
Flurazepam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000207	0.000573	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—BRAF—malignant glioma	0.000206	0.000569	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—BRAF—malignant glioma	0.000205	0.000566	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—RTEL1—malignant glioma	0.000205	0.000565	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000204	0.000564	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—MDM2—malignant glioma	0.000204	0.000563	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000204	0.000563	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—RAF1—malignant glioma	0.000203	0.000561	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000203	0.00056	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—MDM2—malignant glioma	0.000201	0.000556	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—BRAF—malignant glioma	0.000201	0.000555	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—RAF1—malignant glioma	0.000201	0.000554	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000201	0.000554	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000199	0.00055	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000199	0.00055	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—COX8A—malignant glioma	0.000197	0.000546	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000196	0.00054	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000195	0.000539	CbGpPWpGaD
Flurazepam—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000192	0.000532	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000192	0.000531	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000191	0.000529	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000189	0.000523	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—MDM2—malignant glioma	0.000184	0.000509	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—RAF1—malignant glioma	0.000184	0.000507	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ASMT—malignant glioma	0.000183	0.000505	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000183	0.000505	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000183	0.000505	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000182	0.000502	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000182	0.000502	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000181	0.000501	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000181	0.0005	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00018	0.000498	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.00018	0.000497	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—MDM2—malignant glioma	0.000179	0.000494	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—RAF1—malignant glioma	0.000178	0.000493	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000178	0.000492	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000178	0.000491	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000176	0.000487	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000176	0.000486	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—BRAF—malignant glioma	0.000176	0.000485	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—MDM2—malignant glioma	0.000176	0.000485	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—RAF1—malignant glioma	0.000175	0.000484	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000174	0.000481	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—MDM2—malignant glioma	0.000173	0.000477	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—RAF1—malignant glioma	0.000172	0.000475	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—BCAN—malignant glioma	0.000172	0.000475	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—MDM2—malignant glioma	0.000172	0.000474	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—RAF1—malignant glioma	0.000171	0.000472	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000169	0.000466	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—MDM2—malignant glioma	0.000168	0.000465	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ASMT—malignant glioma	0.000168	0.000464	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000168	0.000464	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—RAF1—malignant glioma	0.000168	0.000464	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000164	0.000452	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—BRAF—malignant glioma	0.000161	0.000446	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00016	0.000442	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—BCAN—malignant glioma	0.000158	0.000436	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—COX8A—malignant glioma	0.000156	0.000431	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000154	0.000425	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000153	0.000421	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000149	0.000412	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—MDM2—malignant glioma	0.000147	0.000407	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—RAF1—malignant glioma	0.000147	0.000405	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000146	0.000404	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000142	0.000393	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000142	0.000393	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—AKT1—malignant glioma	0.000141	0.00039	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—IDH2—malignant glioma	0.000139	0.000383	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—MDM2—malignant glioma	0.000135	0.000373	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—RAF1—malignant glioma	0.000135	0.000372	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ASMT—malignant glioma	0.000133	0.000367	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000132	0.000364	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000131	0.000362	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP2B6—malignant glioma	0.00013	0.00036	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—IDH2—malignant glioma	0.000127	0.000352	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000127	0.000351	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000126	0.000348	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000125	0.000347	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—BCAN—malignant glioma	0.000125	0.000345	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000125	0.000344	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000123	0.00034	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP2B6—malignant glioma	0.00012	0.000331	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—IDH1—malignant glioma	0.000119	0.000329	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—COX8A—malignant glioma	0.000117	0.000325	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000117	0.000324	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000115	0.000319	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SPHK1—malignant glioma	0.000115	0.000319	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000113	0.000313	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP2C18—malignant glioma	0.000113	0.000312	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—IDH1—malignant glioma	0.000109	0.000302	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000109	0.000302	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000108	0.000298	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000107	0.000295	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SPHK1—malignant glioma	0.000106	0.000293	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP2C18—malignant glioma	0.000104	0.000287	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000101	0.00028	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—IDH2—malignant glioma	0.000101	0.000278	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.0001	0.000276	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ASMT—malignant glioma	9.99e-05	0.000276	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	9.99e-05	0.000276	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	9.96e-05	0.000275	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	9.87e-05	0.000273	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	9.86e-05	0.000272	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	9.64e-05	0.000266	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—RAF1—malignant glioma	9.59e-05	0.000265	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP2B6—malignant glioma	9.45e-05	0.000261	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	9.41e-05	0.00026	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—BCAN—malignant glioma	9.39e-05	0.00026	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	9.25e-05	0.000256	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—RAF1—malignant glioma	9.19e-05	0.000254	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	9.17e-05	0.000253	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTT1—malignant glioma	9.14e-05	0.000252	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	9.02e-05	0.000249	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	8.95e-05	0.000247	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	8.73e-05	0.000241	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—IDH1—malignant glioma	8.65e-05	0.000239	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTGS1—malignant glioma	8.56e-05	0.000237	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	8.41e-05	0.000232	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTT1—malignant glioma	8.39e-05	0.000232	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SPHK1—malignant glioma	8.37e-05	0.000231	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP2C18—malignant glioma	8.2e-05	0.000226	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—BCHE—malignant glioma	7.96e-05	0.00022	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	7.89e-05	0.000218	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SLC5A5—malignant glioma	7.86e-05	0.000217	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTGS1—malignant glioma	7.86e-05	0.000217	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	7.59e-05	0.00021	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—IDH2—malignant glioma	7.57e-05	0.000209	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—BCHE—malignant glioma	7.31e-05	0.000202	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	7.24e-05	0.0002	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—COX8A—malignant glioma	7.24e-05	0.0002	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SLC5A5—malignant glioma	7.22e-05	0.000199	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP2B6—malignant glioma	7.12e-05	0.000197	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	6.99e-05	0.000193	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	6.83e-05	0.000189	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTT1—malignant glioma	6.63e-05	0.000183	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—IDH1—malignant glioma	6.51e-05	0.00018	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	6.51e-05	0.00018	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	6.45e-05	0.000178	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTP1—malignant glioma	6.33e-05	0.000175	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SPHK1—malignant glioma	6.3e-05	0.000174	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTGS1—malignant glioma	6.21e-05	0.000172	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP2C18—malignant glioma	6.17e-05	0.000171	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CAT—malignant glioma	6.16e-05	0.00017	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ASMT—malignant glioma	6.16e-05	0.00017	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	5.93e-05	0.000164	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—NCOR1—malignant glioma	5.82e-05	0.000161	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTP1—malignant glioma	5.81e-05	0.000161	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—BCAN—malignant glioma	5.79e-05	0.00016	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—BCHE—malignant glioma	5.77e-05	0.00016	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.74e-05	0.000159	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SLC5A5—malignant glioma	5.7e-05	0.000158	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CAT—malignant glioma	5.66e-05	0.000156	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—NCOR1—malignant glioma	5.34e-05	0.000148	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTT1—malignant glioma	4.99e-05	0.000138	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.84e-05	0.000134	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CAV1—malignant glioma	4.74e-05	0.000131	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTGS1—malignant glioma	4.68e-05	0.000129	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—IDH2—malignant glioma	4.66e-05	0.000129	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTP1—malignant glioma	4.59e-05	0.000127	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CAT—malignant glioma	4.47e-05	0.000124	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.39e-05	0.000121	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CAV1—malignant glioma	4.36e-05	0.00012	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—BCHE—malignant glioma	4.35e-05	0.00012	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PIK3CG—malignant glioma	4.32e-05	0.000119	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SLC5A5—malignant glioma	4.3e-05	0.000119	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—NCOR1—malignant glioma	4.22e-05	0.000117	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PPARG—malignant glioma	4.17e-05	0.000115	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—IDH1—malignant glioma	4.01e-05	0.000111	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PIK3CG—malignant glioma	3.97e-05	0.00011	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.96e-05	0.000109	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SPHK1—malignant glioma	3.88e-05	0.000107	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PPARG—malignant glioma	3.83e-05	0.000106	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.8e-05	0.000105	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PIK3CD—malignant glioma	3.8e-05	0.000105	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PIK3CD—malignant glioma	3.49e-05	9.64e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTP1—malignant glioma	3.46e-05	9.56e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CAV1—malignant glioma	3.44e-05	9.51e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CAT—malignant glioma	3.37e-05	9.3e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PIK3CB—malignant glioma	3.31e-05	9.15e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTGS2—malignant glioma	3.28e-05	9.07e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—NCOR1—malignant glioma	3.18e-05	8.79e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PIK3CG—malignant glioma	3.14e-05	8.66e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTT1—malignant glioma	3.08e-05	8.5e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PIK3CB—malignant glioma	3.04e-05	8.4e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PPARG—malignant glioma	3.03e-05	8.36e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTGS2—malignant glioma	3.01e-05	8.32e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTGS1—malignant glioma	2.88e-05	7.96e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTEN—malignant glioma	2.86e-05	7.91e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PIK3CD—malignant glioma	2.76e-05	7.62e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—BCHE—malignant glioma	2.68e-05	7.4e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.65e-05	7.31e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTEN—malignant glioma	2.63e-05	7.26e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CAV1—malignant glioma	2.59e-05	7.16e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PIK3CB—malignant glioma	2.4e-05	6.64e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTGS2—malignant glioma	2.38e-05	6.58e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PIK3CG—malignant glioma	2.36e-05	6.52e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PPARG—malignant glioma	2.28e-05	6.3e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTP1—malignant glioma	2.13e-05	5.89e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTEN—malignant glioma	2.08e-05	5.74e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PIK3CD—malignant glioma	2.08e-05	5.73e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CAT—malignant glioma	2.07e-05	5.73e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PIK3CA—malignant glioma	2.02e-05	5.58e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—NCOR1—malignant glioma	1.96e-05	5.41e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PIK3CA—malignant glioma	1.85e-05	5.12e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PIK3CB—malignant glioma	1.81e-05	5e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTGS2—malignant glioma	1.79e-05	4.95e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—AKT1—malignant glioma	1.65e-05	4.56e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CAV1—malignant glioma	1.6e-05	4.41e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTEN—malignant glioma	1.56e-05	4.32e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—AKT1—malignant glioma	1.51e-05	4.18e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PIK3CA—malignant glioma	1.46e-05	4.05e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.45e-05	4.02e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PPARG—malignant glioma	1.4e-05	3.88e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.28e-05	3.53e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—AKT1—malignant glioma	1.2e-05	3.31e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.11e-05	3.08e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTGS2—malignant glioma	1.1e-05	3.05e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PIK3CA—malignant glioma	1.1e-05	3.05e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTEN—malignant glioma	9.63e-06	2.66e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—AKT1—malignant glioma	9.01e-06	2.49e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.79e-06	1.88e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—AKT1—malignant glioma	5.55e-06	1.53e-05	CbGpPWpGaD
